Acacia appoints new CEO

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Acacia appoints new CEO

Acacia Research has appointed Matthew Vella, Acacia’s president, as chief executive officer and a director effective August 1 2013.

Vella, who will continue to serve as president of Acacia, is taking over from Paul Ryan, Acacia’s present chief executive officer and a director. Ryan is retiring and will resign effective July 31 2013.

Vella joined Acacia in November 2006 as vice president. He was appointed senior vice president in October 2007, executive vice president in October 2011 and president in September 2012. Prior to joining Acacia, he was senior intellectual property counsel for ATI Research and lead patent license counsel for Nortel Networks.

more from across site and SHARED ros bottom lb

More from across our site

Tarun Khurana at Khurana & Khurana says corporates must take the lead if patent filing activity is to truly translate into innovation
Michael Moore, head of legal at Glean AI, discusses how in-house IP teams can use AI while protecting enforceability
Counsel for SEP owners and implementers are keeping an eye on the case, which could help shape patent enforcement strategy for years to come
Jacob Schroeder explains how he and his team secured victory for Promptu in a long-running patent infringement battle with Comcast
After Matthew McConaughey registered trademarks to protect his voice and likeness against AI use, lawyers at Skadden explore the options available for celebrities keen to protect their image
The Via members, represented by Licks Attorneys, target the Chinese company and three local outfits, adding to Brazil’s emergence as a key SEP litigation venue
The firm, which has revealed profits of £990,837, claims it is the disruptive force in the IP-legal industry
In the first of a two-parter, lawyers at Santarelli analyse the patentability of therapeutic inventions where publication of clinical trial protocols occurs before the application's filing date
Arun Hill at Clarivate assesses the Top 100 Global Innovators 2026 list, including why AI has assumed a strategic importance for innovation
Practitioners and law firms should keep their eyes peeled for the shortlists for our annual awards
Gift this article